Home›Nephrology› Gut-kidney axis drives sepsis-associated AKI, review argues for microecological and neuromodulatory therapies
Gut-kidney axis drives sepsis-associated AKI, review argues for microecological and neuromodulatory therapiesNew Approaches Target Gut Health to Treat Sepsis Kidney Damage
Frontiers in MedicinePublished September 13, 2026DOI ↗Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Interpret gut-kidney axis therapies as mechanistic hypotheses, not proven SA-AKI treatments.
This systematic review focuses on the gut-kidney axis as a mechanistic framework for sepsis-associated acute kidney injury (SA-AKI) and on novel therapeutic approaches that target it. The interventions discussed include microecological modulation, targeted anti-inflammatory immunotherapy, traditional Chinese medicine interventions, and vagus nerve electrical stimulation.
The review describes a proposed cycle in which intestinal barrier disruption and dysbiosis in SA-AKI trigger pathogenic translocation, immune cell infiltration, and imbalances in nephrotoxic metabolites, leading to renal inflammatory storms. This mechanistic model is presented as the rationale for the therapeutic strategies reviewed.
The review does not report a study population, sample size, comparator, primary outcome, follow-up duration, or adverse events. No effect sizes, p-values, or confidence intervals are provided. The authors explicitly note that the review discusses theoretical mechanisms and potential therapeutic pathways rather than clinical trial results.
Limitations acknowledged in the source are not reported, and funding or conflicts of interest are not reported. Because the evidence is mechanistic and no clinical outcomes are synthesized, the practice relevance remains exploratory. The review evaluates novel therapeutic approaches to prevent and treat SA-AKI by targeting the gut-kidney axis, but clinicians should interpret these findings as hypothesis-generating rather than practice-changing.
How this fits prior evidence
This review extends prior coverage of sepsis and AKI by shifting focus from prognostic markers and adjunctive therapies to a mechanistic gut-kidney axis. Prior items noted associations between admission hypoalbuminemia and increased AKI and mortality in burn patients, higher PNI scores and lower short-term mortality in sepsis, and butyrylcholinesterase activity as a mortality predictor. Another prior item reported that intravenous vitamin C was associated with reduced mortality in sepsis and septic shock, though evidence quality was low. The present review does not confirm or contrast these clinical findings; it addresses a gap by synthesizing theoretical mechanisms and potential therapeutic pathways rather than trial outcomes.
This review looks at how the gut and kidneys work together, a connection called the gut-kidney axis. In patients with sepsis, the gut barrier can break down. This allows harmful bacteria and toxins to enter the body, which can cause severe inflammation and damage to the kidneys.
Researchers are looking at several ways to address this problem. These include changing the gut's environment, using specific immune therapies, and using traditional Chinese medicine. They are also looking at electrical stimulation of the vagus nerve. These methods aim to stop the cycle of inflammation that harms the kidneys.
It is important to note that this review focuses on theoretical pathways and potential treatments. It does not provide results from clinical trials. Because these methods are still being explored, they are not currently standard treatments. Patients should talk to their doctors about the best ways to manage sepsis and kidney health.
What this means for you:
New research explores how targeting the gut-kidney axis may help manage kidney damage caused by sepsis.
Common questions
What is the gut-kidney axis?
The gut-kidney axis is the connection between the gut and the kidneys. In patients with sepsis, a breakdown in the gut barrier can lead to a cycle of inflammation. This happens because harmful substances move into the body and cause a storm of inflammation that damages the kidneys.
What new treatments are being studied for sepsis-related kidney injury?
Researchers are looking at several potential approaches. These include microecological modulation, targeted anti-inflammatory immunotherapy, traditional Chinese medicine, and vagus nerve electrical stimulation. These methods aim to treat the gut-kidney axis to prevent kidney damage.
Are these treatments currently available for patients?
These methods are currently being studied as potential therapeutic pathways. Because this review focuses on theoretical mechanisms rather than clinical trial results, these are not yet standard treatments. You should consult a medical professional regarding current treatment options.
Sepsis-associated acute kidney injury (SA-AKI) is a common, high-mortality complication in critically ill patients, necessitating breakthroughs in prevention and treatment strategies. The “gut-kidney axis” theory offers a novel perspective. This review delves into the vicious cycle triggered by intestinal barrier disruption and dysbiosis in SA-AKI: pathogenic translocation, immune cell infiltration, and imbalances in nephrotoxic metabolites collectively drive renal inflammatory storms. Building upon these mechanisms, we systematically evaluate novel therapeutic approaches centred on microecological modulation, targeted anti-inflammatory immunotherapy, traditional Chinese medicine interventions, and vagus nerve electrical stimulation. These strategies aim to pioneer new pathways for the precise prevention and treatment of SA-AKI.
